AIDX
$2.16
Post-MarketAs of Mar 17, 8:00 PM UTC
20/20 GeneSystems, Inc.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.16
Potential Upside
5%
Whystock Fair Value$2.27
Price
UndervaluedFair ValueOvervalued
Fundamentals
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$22.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.64
Recent News
No recent news found.